Certara, Inc. (CERT) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 EQT Avatar Parent L.P. 37,458,939 주 보유. 기타 주요 보유자에는 ARSENAL CAPITAL INVESTMENT VI LP 및 EQT Fund Management S.a r.l..
지난 12개월간 내부자는 27 건의 거래를 수행 CERT 주식 — 9 건 매수 (평가액 $200K) 및 1 건 매도 (평가액 $559.37K). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.
CERT 내부자 보유 현황
최대 보유자
EQT Avatar Parent L.P.
37,458,939 주
내부자 주요 보유자
| # |
이름 |
직책 |
보유 주식수 |
최종 신고일 |
상대적 규모 |
| 1 |
Eqt Avatar Parent L.p. |
10 Percent Owner |
37,458,939 |
2021-11-24 |
|
| 2 |
Arsenal Capital Investment Vi Lp |
Director |
36,345,835 |
2022-12-16 |
|
| 3 |
Eqt Fund Management S.a R.l. |
Director |
29,954,521 |
2022-08-17 |
|
| 4 |
Feehery William F |
Chief Executive Officer |
2,360,769 |
2025-11-12 |
|
| 5 |
Slaine Mason P |
Director |
906,115 |
2022-11-16 |
|
| 6 |
Mccoy Sherilyn S |
Director |
621,143 |
2021-05-18 |
|
| 7 |
Rayner Craig R. |
President, Integrated Drug Dev |
316,010 |
2021-09-07 |
|
| 8 |
Dickinson Judith |
See Remarks |
173,564 |
2021-04-09 |
|
| 9 |
Pedersen Leif E |
President, Chief Commercal Off |
73,979 |
2025-09-11 |
|
| 10 |
Gallagher John E |
Chief Financial Officer |
68,348 |
2025-05-22 |
|
| 11 |
Smith Patrick F |
President, Drug Dev Solutions |
50,091 |
2024-10-08 |
|
| 12 |
Aspbury Robert |
President, Predictive Tech |
45,566 |
2025-05-22 |
|
| 13 |
Mclean Stephen M. |
Director |
42,000 |
2022-08-23 |
|
| 14 |
Schemick Michael Andrew |
Chief Financial Officer |
26,604 |
2023-04-03 |
|
| 15 |
Edge Justin |
Pres., Regulatory & Access |
25,939 |
2022-04-05 |
|
| 16 |
Corcoran Daniel |
SVP and General Counsel |
21,319 |
2026-04-03 |
|
| 17 |
Choe Jieun W. |
Chief Strategy & Marketing |
15,962 |
2022-04-05 |
|
| 18 |
Anhalt Rona |
Chief Human Resources Officer |
11,883 |
2026-04-03 |
|
| 19 |
Reynders John V W |
Director |
10,709 |
2024-10-18 |
|
| 20 |
Broshy Eran |
Director |
9,553 |
2023-08-23 |
|
최근 거래 (최근 12개월)
| 날짜 |
이름 |
직책 |
유형 |
주식수 |
주가 |
금액 |
| 2026-04-01 |
Mckemey Adrian |
President, Drug Dev. Solutions |
RSU 원천징수 |
2,642 |
$5.70 |
$15.06K |
| 2026-04-01 |
Corcoran Daniel |
SVP and General Counsel |
RSU 원천징수 |
5,751 |
$5.70 |
$32.78K |
| 2026-04-01 |
Anhalt Rona |
Chief Human Resources Officer |
RSU 원천징수 |
3,062 |
$5.70 |
$17.45K |
| 2026-04-01 |
Aspbury Robert |
President, Predictive Tech |
옵션 행사 (매도) |
7,852 |
- |
- |
| 2026-04-01 |
Gallagher John E |
Chief Financial Officer |
옵션 행사 (매도) |
12,633 |
- |
- |
| 2026-04-01 |
Pedersen Leif E |
President, Chief Commercal Off |
옵션 행사 (매도) |
7,852 |
- |
- |
| 2026-02-27 |
Bedi Arjun |
Director |
RSU 부여 |
5,547 |
- |
- |
| 2026-02-24 |
Bedi Arjun |
Officer |
알 수 없음 |
- |
- |
- |
| 2026-01-01 |
Resnick Jon Matthew |
Officer |
알 수 없음 |
- |
- |
- |
| 2025-11-11 |
Feehery William F |
Chief Executive Officer |
정보 매수 |
24,096 |
$8.30 |
$200K |
| 2025-09-09 |
Pedersen Leif E |
President, Chief Commercal Off |
정보 매도 |
51,224 |
$10.92 |
$559.37K |
| 2025-05-30 |
Corcoran Daniel |
SVP and General Counsel |
RSU 원천징수 |
2,298 |
$11.40 |
$26.2K |
| 2025-05-30 |
Anhalt Rona |
Chief Human Resources Officer |
RSU 원천징수 |
1,965 |
$11.40 |
$22.4K |
| 2025-05-20 |
Mckemey Adrian |
President, Drug Dev. Solutions |
RSU 부여 |
32,547 |
- |
- |
| 2025-05-21 |
Reynders John V W |
Director |
옵션 행사 (매도) |
10,709 |
- |
- |
| 2025-05-20 |
Corcoran Daniel |
SVP and General Counsel |
RSU 부여 |
32,547 |
- |
- |
| 2025-05-20 |
Anhalt Rona |
Chief Human Resources Officer |
RSU 부여 |
29,292 |
- |
- |
| 2025-05-20 |
Aspbury Robert |
President, Predictive Tech |
RSU 부여 |
45,566 |
- |
- |
| 2025-05-20 |
Gallagher John E |
Chief Financial Officer |
RSU 부여 |
68,348 |
- |
- |
| 2025-05-21 |
Killefer Nancy |
Director |
옵션 행사 (매도) |
11,928 |
- |
- |
| 2025-05-20 |
Pedersen Leif E |
President, Chief Commercal Off |
RSU 부여 |
45,566 |
- |
- |
| 2025-05-20 |
Feehery William F |
Chief Executive Officer |
RSU 부여 |
187,144 |
- |
- |
| 2025-05-21 |
Crane Rosemary A |
Director |
옵션 행사 (매도) |
11,928 |
- |
- |
| 2025-05-21 |
Collins Cynthia |
Director |
옵션 행사 (매도) |
11,928 |
- |
- |
| 2025-05-21 |
Walsh Matthew M |
Director |
옵션 행사 (매도) |
11,928 |
- |
- |
